Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0321-05

BD, Proteus Polyvalent Antiserum (OXK, OX2, OX19)

Lee Laboratories, Inc. / initiated 2004-10-20 / Terminated

BD Diagnostic Systems began a recall of BD, Proteus Polyvalent Antiserum (OXK, OX2, OX19) on . The reason FDA records is "Febrile Antigens and Control Antisera that were released prior to August 2003 contained the 12/2000 revised insert that had incorrect testing instructions". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0321-05
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Lee Laboratories, Inc.
Product
BD, Proteus Polyvalent Antiserum (OXK, OX2, OX19)
Product code
GSY Antisera, Fluorescent, All Globulins, Proteus Spp.
Reason for recall
Febrile Antigens and Control Antisera that were released prior to August 2003 contained the 12/2000 revised insert that had incorrect testing instructions.
FDA root cause
Other
Action
Consignees were notified by letter beginning 10/20/2004.
Quantity in commerce
100 vials (5ml per vial)
Distribution
Nationwide, Australia, Belgium, Canada, Chile, Ecuador, India, Korea, Malaysia, New Zealand, Singapore, Taiwan
Product codes and lots
Catalogue #240490, Lot #3079439